Functional Dyspepsia Drug Market Revenue 2024 to 2034
Functional Dyspepsia Drug Market Revenue 2024 to 2034
Functional Dyspepsia Drug Market: Increasing at 8.01% CAGR, the market will grow from USD 3.72 Bn in 2024 to USD 8.04 Bn by 2034, driven by digestive disorder prevalence and gastrointestinal R&D.
Report ID: 10448
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 3.72 Bn
Forecast Year,
USD 8.04 Bn
CAGR, 2025 -
8.01%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Functional Dyspepsia Drug Market Size Analysis
Functional Dyspepsia Drug Market Size By Modality 2024 to 2034 (USD )
| Modality | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRI/CT/US Platforms | 1.34 | 1.45 | 1.57 | 1.70 | 1.83 | 1.98 | 2.14 | 2.30 | 2.49 | 2.69 | 2.92 |
| X-ray/Fluoroscopy | 0.67 | 0.72 | 0.78 | 0.84 | 0.91 | 0.97 | 1.04 | 1.13 | 1.22 | 1.31 | 1.42 |
| PET/SPECT | 0.60 | 0.65 | 0.69 | 0.75 | 0.81 | 0.88 | 0.95 | 1.03 | 1.11 | 1.21 | 1.30 |
| Software/AI | 0.67 | 0.72 | 0.78 | 0.84 | 0.90 | 0.98 | 1.06 | 1.14 | 1.23 | 1.32 | 1.43 |
| Other | 0.45 | 0.48 | 0.51 | 0.56 | 0.61 | 0.66 | 0.71 | 0.77 | 0.83 | 0.90 | 0.97 |
Functional Dyspepsia Drug Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 1.26 | 1.36 | 1.46 | 1.59 | 1.72 | 1.85 | 2.00 | 2.17 | 2.34 | 2.54 | 2.75 |
| Cardiology | 0.67 | 0.73 | 0.79 | 0.86 | 0.92 | 0.99 | 1.08 | 1.15 | 1.25 | 1.35 | 1.46 |
| Neurology | 0.60 | 0.64 | 0.69 | 0.75 | 0.81 | 0.87 | 0.94 | 1.01 | 1.09 | 1.18 | 1.26 |
| Orthopedics | 0.45 | 0.48 | 0.52 | 0.57 | 0.61 | 0.67 | 0.71 | 0.77 | 0.83 | 0.89 | 0.96 |
| Others | 0.74 | 0.80 | 0.87 | 0.93 | 1.00 | 1.09 | 1.18 | 1.28 | 1.38 | 1.49 | 1.61 |
Functional Dyspepsia Drug Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 2.16 | 2.33 | 2.51 | 2.71 | 2.95 | 3.18 | 3.44 | 3.72 | 4.02 | 4.34 | 4.69 |
| Imaging Centers | 0.97 | 1.04 | 1.13 | 1.22 | 1.31 | 1.41 | 1.53 | 1.65 | 1.78 | 1.93 | 2.08 |
| Academic/Research | 0.45 | 0.48 | 0.52 | 0.57 | 0.61 | 0.65 | 0.71 | 0.76 | 0.82 | 0.88 | 0.95 |
| Others | 0.15 | 0.16 | 0.17 | 0.19 | 0.20 | 0.22 | 0.23 | 0.25 | 0.27 | 0.30 | 0.32 |
Functional Dyspepsia Drug Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.56 | 1.69 | 1.83 | 1.98 | 2.15 | 2.32 | 2.52 | 2.72 | 2.94 | 3.16 | 3.41 |
| Europe | 1.04 | 1.13 | 1.21 | 1.30 | 1.40 | 1.51 | 1.63 | 1.76 | 1.90 | 2.06 | 2.24 |
| Asia Pacific | 0.89 | 0.96 | 1.04 | 1.12 | 1.21 | 1.31 | 1.41 | 1.52 | 1.64 | 1.78 | 1.92 |
| Latin America | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.19 | 0.20 | 0.22 | 0.23 |
| Middle East & Africa | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.19 | 0.20 | 0.22 | 0.24 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
